Optimas Capital’s Merck MRK Stock Holding History

Optimas Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-122,300	Closed	-$10.3M	–	27
2025 Q3	$10.3M	Buy	+122,300	New	+$10.1M	6.49%	4
2024 Q3	–	Sell	-111,600	Closed	-$14.2M	–	31
2024 Q2	$14.2M	Buy	111,600 +51,735	+86%	+$6.66M	16.16%	1
2024 Q1	$7.9M	Buy	59,865 +37,165	+164%	+$4.58M	6.91%	4
2023 Q4	$2.47M	Buy	22,700 +429	+2%	+$44.5K	2.33%	19
2023 Q3	$2.29M	Sell	22,271 -9,129	-29%	-$984K	1.57%	18
2023 Q2	$3.62M	Buy	+31,400	New	+$3.57M	4.19%	10

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Optimas Capital's MRK Position: Q4 2025 in Review

Optimas Capital sold out of Merck (MRK) in Q4 2025, closing a stake of 122,300 shares — an estimated $10.3M sold.

Optimas Capital first reported a position in MRK in Q2 2023 and held it in 6 quarters. The position peaked at $14.2M in Q2 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

Optimas Capital reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
Optimas Capital sold 122,300 Merck shares in Q4 2025, an estimated $10.3M.
Optimas Capital first reported a position in Merck in Q2 2023 and held it in 6 quarters.
Optimas Capital's Merck position peaked at $14.2M in Q2 2024.
3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Optimas Capital's 13F filing for Q4 2025, filed 11 Feb 2026.